Associate Professor of Pharmaceutical Technology and Pharmaceutical Biotechnology and Researcher at FP-I3ID, FP-BHS, Faculty of Health Sciences, University Fernando Pessoa, Porto, Portugal. Senior Researcher at UCIBIO, Faculty of Pharmacy, University of Porto, Portugal. European PhD in Pharmaceutical Sciences with specialization in Pharmaceutical Technology from University of Porto. Graduation in Pharmaceutical Sciences from University Fernando Pessoa. Author of several works in the areas of Pharmaceutical Technology and Pharmaceutical Biotechnology (h-index of 28): > 57 articles, 1 book, 6 book chapters, 60 posters, 15 oral communications; editor of 6 books; invited editor of 12 special issues. Included in the World's Top 2% Scientists List, in 2021, 2022, 2023 and 2024, by Stanford University, USA. PI of the UCIBIO/FFUP group in the project "Marie waste biorefinery: bioactive platforms for a circular cosmetic industry" (MPr-12-2023 - ICDT/2023 FCT-funded project nº16862). PI of the UCIBIO/FFUP group in the project "Shrimp4NanoCosmetics project - New Nanotechnology-Based Cosmetic Products Obtained through Advanced Marine Biomass Extraction and Valorisation Technologies" (Ref. COMPETE2030-FEDER-01199900). Investigator in 2 R&D FCT-funded projects (Ref. PTDC/SAU-FAR/112277/2009 and PTDC_SAU_FCF_70651_2006). Referee for >10 international funding agencies and >50 journals. Supervisor of 6 FCT funded PhD students (2 completed), 6 MSc students (5 completed), and 40 undergraduate students (37 completed). Member of the editorial board of the Springer book series: Advances in Biochemical Engineering/Biotechnology; Dermatological Drug Delivery from Frontiers in Drug Delivery; Chinese Chemical Letters; Current Drug Metabolism; and Biochemistry & Pharmacology: Open Access. Member of the Board of the Northern Regional Section of the Order of Pharmacists, since 2025. Invited member of the "Conselho para a Qualificação e Admissão", Order of Pharmacists, Portugal, since 2022. 1st Secretary of the Regional Assembly, Northern Regional Section, Order of Pharmacists, Porto, Portugal, between 2019 and 2025. Current research interests are focused on developing lipid-based nanosystems to improve drug delivery. In particular, nose-to-brain delivery and cutaneous delivery; the quality-by-design (QbD) approach to optimize formulations of lipid-based nanosystems; and the development of Biopharmaceuticals and Advanced Therapy Medicinal Products (ATMPs).